Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Urinary Angiotensinogen as a Marker to Warn the Deterioration of Renal Function in CKD Patients Early.

NCT01118494 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT01118494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01118494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Urinary Angiotensinogen as a Marker to Warn the Deterioration of Renal Function in CKD Patients Early.
Lead sponsor
Fudan University
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2009
Completion date
June 30, 2011
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, urinary angiotensinogen